Overcoming the defects of a virtue - Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: The detect supraventricular tachycardia study

Circulation

Volumn 113, Issue 25, 2006, Pages 2862-2864

  Sweeney, Michael O ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC PATIENT; DEFIBRILLATOR; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EDITORIAL; ELECTROGRAPHY; HEART ATRIUM FIBRILLATION; HEART RATE; HEART RHYTHM; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYBRIDIZATION; PRIORITY JOURNAL; QRS COMPLEX; SENSITIVITY AND SPECIFICITY; SINUS TACHYCARDIA; SUPRAVENTRICULAR TACHYCARDIA; CARDIOVERSION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART ATRIOVENTRICULAR NODE; INSTRUMENTATION; METHODOLOGY; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STANDARD; TIME;

ARRHYTHMIA; ATRIOVENTRICULAR NODE; DEFIBRILLATORS, IMPLANTABLE; DIAGNOSIS, DIFFERENTIAL; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; HEART RATE; HUMANS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, SUPRAVENTRICULAR; TACHYCARDIA, VENTRICULAR; TIME FACTORS; VENTRICULAR FIBRILLATION;

EID: 33747148522     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.634113     Document Type: Editorial

References (19)

1. Brugada J, Mont L, Figueiredo M, Valentino M, Matas M, Navarro-Lopez F. Enhanced detection criteria in implantable defibrillators. J Cardiovasc Electrophysiol. 1998;9:261-268.
2. Kettering K, Dornberger V, Lang R, Vonthein R, Suchalla R, Bosch RF, Mewis C, Eigenberger B, Kuhlkamp V. Enhanced detection criteria in implantable cardioverter defibrillators: sensitivity and specificity of the stability algorithm at different heart rates. Pacing Clin Electrophysiol. 2001;24:1325-1333.
3. Gronefeld GC, Schulte B, Hohnloser SH, Trappe HJ, Korte T, Stellbrink C, Jung W, Meesmann M, Bocker D, Grosse-Meininghaus D, Vogt J, for the German MD Study Group. Morphology discrimination: a beat-to-beat algorithm for the discrimination of ventricular from supraventricular tachycardia by implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2001;24:1519-1524.
4. Swerdlow CD, Brown ML, Lurie K, Zhang J, Wood NM, Olson WH, Gillberg JM. Discrimination of ventricular tachycardia from supraventricular tachycardia by a downloaded wavelet-transform algorithm: a paradigm for development of implantable cardioverter defibrillator detection algorithms. J Cardiovasc Electrophysiol. 2002;13:432-441.
5. Wilkoff BL, Kühlkamp V, Volosin K, Ellenbogen K, Waldecker B, Kacet S, Gillberg J, DeSouza CM. Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection results and technical considerations. Circulation. 2001;103:381-386.
6. Kouakam C, Kacet S, Hazard JR, Ferraci A, Mansour H, Defaye P, Davy J, Lambiez M, for the Ventak AV Investigators. Performance of a dualchamber implantable defibrillator algorithm for discrimination of ventricular from supraventricular tachycardia. Europace. 2004;6:32-42.
7. Sadoul N, Jung W, Jordaens L, Leenhardt A, Santini M, Wolpert C, Aliot E, for the Defender I and II Clinical Trial Investigators. Diagnostic performance of a dual-chamber cardioverter defibrillator programmed with nominal settings: a European prospective study. J Cardiovasc Electrophysiol. 2002;13:25-32.
8. Deisenhofer I, Kolb C, Ndrepepa G, Schreieck J, Karch M, Schmieder S, Zrenner B, Schmitt C. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized prospective study. J Cardiovasc Electrophysiol. 2001;12:134-142.
9. Bansch D, Steffgen F, Gronefeld G, Wolpert C, Bocker D, Mletzko RU, Schols W, Seidl K, Piel M, Ouyang F, Hohnloser SH, Kuck KH. The 1 + 1 Trial: a prospective trial of dual- versus single-chamber implantable defibrillator in patients with slow ventricular tachycardias. Circulation. 2004;110:1022-1029.
10. Theuns DAMJ, Klootwijk PJ, Goedhart DM, Jordaens LJLM. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol. 2004;44:2362-2367.
11. Dorian P, Phillipon F, Thibault B, Kimber S, Sterns L, Greene M, Newman D, Gelaznikas R, Barr A, for the ASTRID Investigators. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. Heart Rhythm. 2004;1:540-547.
12. Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM, Kavesh NG, Wood M, Daoud E, Massumi A, Schuger C, Shorofsky S, Wilkoff B, Glikson M. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the Detect Supraventricular Tachycardia Study. Circulation. 2006;113:2871-2879.
13. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin JK, for the PainFREE Rx II Investigators. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter defibrillators: PainFREE Rx II Trial Results. Circulation. 2004;110:2592-2596.
14. Gold MR, Shorofsky SR, Thompson JA, Kim J, Schwartz M, Bocek J, Lovett EG, Hsu W, Morris MM, Lang DJ. Advanced rhythm discrimination for implantable cardioverter defibrillators using electrogram vector timing and correlation. J Cardiovasc Electrophysiol. 2002;13:1092-1097.
15. Hintringer F, Deibl M, Berger T, Pachinger O, Roithinger FX. Comparison of the specificity of implantable dual chamber defibrillator detection algorithms. Pacing Clin Electrophysiol. 2004;27:976-982.
16. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
17. Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF, Stark AJ. Appropriate and inappropriate ventricular therapies, quality of life and mortality among primary and secondary prevention ICD patients: results from PainFREE Rx II. Circulation. 2005;111:2898-2905.
18. Namerow PB, Firth BR, Heywood GM, Windle JR, Parides MK, for the CABG Patch Trial Investigators and Coordinators. Quality of life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG Patch Trial. Pacing Clin Electrophysiol. 1999;22:1305-1313.
19. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, Kutalek SP, Friedman PL, Bubien RS, Page RL, Powell J, for the AVID Investigators. Quality of life in the Antiarrhythmics Versus Implantable Defibrillators Trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. 2002;105:589-594.